Back to search

Sarissa Biomedical Limited

04581254

liquidation
Private Limited Company
england wales
Companies House
Insolvency history
Health Score
N/A

Details

C/O JAMES COWPER KRESTON THE WHITE BUILDING, SOUTHAMPTON, SO15 2NP
Incorporated 04/11/2002

Compliance

Last accounts

31/12/2019

total exemption full

Accounts

Up to date

Confirmation statement

Last: 04/11/2020

Due

On track

Industry

21100
Manufacture of basic pharmaceutical products

Officers

Nicholas Egerton Dale

secretary · Since 04/11/2002

BRITISH · UNITED KINGDOM · Age 66

Also on 7 other boards

Nicholas Egerton Dale

director · Since 04/11/2002

COMPANY DIRECTOR

BRITISH · UNITED KINGDOM · Age 66

Also on 7 other boards

Mercia Fund Management (Nominees) Limited

director · Since 18/02/2016

BRITISH

Also on 109 other boards

Mr George Thomas Zajicek

director · Since 22/08/2017

DIRECTOR

BRITISH · SCOTLAND · Age 77

Also on 2 other boards

Dr John Michael Clarkson

director · Since 01/06/2019

DIRECTOR

BRITISH · ENGLAND · Age 69

Also on 1 other board

Michael Zelin

director · Since 04/11/2020

DIRECTOR

AMERICAN · UNITED STATES · Age 65

Persons with Significant Control

Mercia Fund Management Limited

25–50% shares
25–50% votes

17, High Street, Henley-In-Arden, B95 5AA

Reg: 06973399 · Registrar Of Companies · Limited Company

Notified 01/11/2018

Former PSCs

The Mercia Fund 1

Ceased 01/11/2018

Insolvency History1 case

creditors voluntary liquidation17/03/2021

Sandra Lillian Mundy (practitioner) · Thomas Charles Russell (practitioner)

CompanyRankvs 2030+ SIC 21100 peers
56

Financial strength64th percentile among SIC peers · 16/25
Employees90th percentile among SIC peers · 14/15
LiquidityCurrent ratio 1.8× · 16/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10Insolvency history -10
Show leaderboard
How is this score calculated?
Financial strength16/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Insolvency history: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

supporting the company for the foreseeable future. They therefore conclude that there are no material uncertainties which may cast significant doubt regarding the company's ability to continue as a going concern. Accordingly, the company continues to adopt the going concern basis in preparing the annual report and accounts. Turnover Turnover is measured at the fair value of the consideration recei

Key FinancialsYear ending 31/12/2019

Net Worth

£10k

Balance sheet strength

Cash

£312k

Cash in the bank

Net Current Assets

£253k

Working capital

Current Assets

£571k

Current Liabilities

£318k

Fixed Assets

£88k

Debtors

£259k

13avg. employees+3

Balance Sheet

Assets less current liabilities£341k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20191.80+£4k
20180.90

Derived from filed accounts. Not audited figures.